NCT03640559View on ClinicalTrials.gov

Safety and Tolerability of Seroguard Use

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 19, 2015

Primary Completion Date

October 4, 2015

Study Completion Date

October 4, 2015

Conditions
Adhesion
Interventions
DRUG

Seroguard

DRUG

Placebos

Sponsors

Lead Sponsor

Pharmasyntez
All Listed Sponsors
collaborator

Sciencefiles

UNKNOWN

lead

Pharmasyntez

INDUSTRY

NCT03640559 - Safety and Tolerability of Seroguard Use | Biotech Hunter | Biotech Hunter